Familial hypomagnesemia with hypercalciuria and nefrocalcinosis due to a mutation in the CLDN16 gen (Claudina 16). A case report
DOI:
https://doi.org/10.20453/rmh.v35i3.5335Keywords:
Claudin, magnesium deficiency, nephrocalcinosis, kidney transplantation, hypocalcemiaAbstract
We report the case of a girl with a history of seizures associated with persistent severe hypomagnesemia, hypocalcemia, hypercalciuria, accompanied by alterations in renal function, metabolic acidosis and Nephrocalcinosis with progression to stage 5 chronic kidney disease (CKD) with a family history of chronic kidney disease, kidney stones and consanguinity of the parents, which is why the genetic study was carried out, resulting in a pathogenic mutation in homozygosity c.446 G>A (p.R149Q) located in exon 3 of the CLDN16 gene, which allows etiological diagnostic confirmation of a case of Hypomagnesemia Familial with Hypercalciuria and Nephrocalcinosis (HFHNC), without severe ocular defects. In addition , the post-transplant evolution with good graft survival is presented.
Downloads
References
Fraga Rodríguez GM, Huertes Díaz B. Evaluación básica de la función renal en Pediatría. Protoc diagn ter pediatr. 2014;1;21-35.
Lv F, Xu XJ, Wang JY, Liu Y, Jiang Y, Wang O, Xia WB, Xing XP, Li M. A novel mutation in CLDN16 results in rare familial hypomagnesaemia with hypercalciuria and nephrocalcinosis in a Chinese family. Clin Chim Acta. 2016 Jun 1; 457:69-74. doi: 10.1016/j.cca.2016.04.004.
Perdomo-Ramirez A, Aguirre M, Davitaia T, Ariceta G, Ramos-Trujillo E; RenalTube Group; Claverie-Martin F. Characterization of two novel mutations in the claudin-16 and claudin-19 genes that cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Gene. 2019 Mar 20; 689:227-234. doi: 10.1016/j.gene.2018.12.024.
Hou J, Goodenough DA. Claudin-16 and claudin-19 function in the thick ascending limb. Curr Opin Nephrol Hypertens. 2010 Sep;19(5):483-8. doi: 10.1097/MNH.0b013e32833b7125.
Benigno V, Canonica CS, Bettinelli A, von Vigier RO, Truttmann AC, Bianchetti MG. Hypomagnesaemia-hypercalciuria-nephrocalcinosis: a report of nine cases and a review. Nephrol Dial Transplant. 2000 May;15(5):605-10. doi: 10.1093/ndt/15.5.605.
Deeb A, Abood SA, Simon J, Dastoor H, Pearce SH, Sayer JA. A novel CLDN16 mutation in a large family with familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. BMC Res Notes. 2013 Dec 10; 6:527. doi: 10.1186/1756-0500-6-527.
Sikora P, Zaniew M, Haisch L, Pulcer B, Szczepańska M, Moczulska A, Rogowska-Kalisz A, Bieniaś B, Tkaczyk M, Ostalska-Nowicka D, Zachwieja K, Hyla-Klekot L, Schlingmann KP, Konrad M. Retrospective cohort study of familial hypomagnesaemia with hypercalciuria and nephrocalcinosis due to CLDN16 mutations. Nephrol Dial Transplant. 2015 Apr;30(4):636-44. doi: 10.1093/ndt/gfu374.
Tajima T, Nakae J, Fujieda K. Two heterozygous mutations of CLDN16 in a Japanese patient with FHHNC. Pediatr Nephrol. 2003 Dec;18(12):1280-2. Doi: 10.1007/s00467-003-1304-0.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Reyner Loza, Fernando Arias Caceres, Victor Neyra Chagua
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors assign their rights to the RMH so that may disseminate the article through the means at their disposal. The journal will provide forms of affidavit of authorship and authorization for the publication of the article, which shall be submitted with the manuscript. Authors retain the right to share, copy, distribute, perform and publicly communicate their article, or part of it, mentioning the original publication in the journal.
